학술논문

COVID-19: The question of genetic diversity and therapeutic intervention approaches
Document Type
article
Author
Figueiredo, David Livingstone AlvesXimenez, João Paulo BianchiSeiva, Fábio Rodrigues FerreiraPanis, CarolinaBezerra, Rafael dos SantosFerrasa, AdrianoCecchini, Alessandra LourençoMedeiros, Alexandra Ivo deAlmeida, Ana Marisa FuscoRamão, AnelisaBoldt, Angelica Beate WinterMoya, Carla FredrichsenChin, Chung ManPaula, Daniel deRech, DanielGradia, Daniela FioriMalheiros, DanielleVenturini, DanielleTavares, Eliandro ReisCarraro, EmersonRibeiro, Enilze Maria de Souza FonsecaPereira, Evani MarquesTuon, Felipe FranciscoFollador, Franciele Aní CaovillaFernandes, Glaura Scantamburlo AlvesVolpato, HélitoCólus, Ilce Mara de SyllosOliveira, Jaqueline Carvalho deRodrigues, Jean Henrique da SilvaSantos, Jean Leandro dosVisentainer, Jeane Eliete LaguilaBrandi, Juliana CristinaSerpeloni, Juliana MaraBonini, Juliana SartoriOliveira, Karen Brajão deFiorentin, KarineLucio, Léia CarolinaFaccin-Galhardi, Ligia CarlaFerreto, Lirane Elize DefanteLioni, Lucy Megumi YamauchiConsolaro, Marcia Edilaine LopesVicari, Marcelo RicardoArbex, Marcos AbdoPileggi, MarcosWatanabe, Maria Angelica EharaCosta, Maria Antônia RamosGiannini, Maria José S. MendesAmarante, Marla KarineKhalil, Najeh MaissarLima Neto, Quirino Alves deHerai, Roberto H.Guembarovski, Roberta LosiShinsato, Rogério N.Mainardes, Rubiana MaraGiuliatti, SilvanaYamada-Ogatta, Sueli FumieGerber, Viviane Knuppel de QuadrosPavanelli, Wander RogérioSilva, Weber Claudio daPetzl-Erler, Maria LuizaValente, ValeriaSoares, Christiane PiennaCavalli, Luciane ReginaSilva Jr, Wilson Araujo
Source
Genetics and Molecular Biology. January 2021 44(1)
Subject
COVID-19
therapeutic interventions
global health treat
virus diversity
Language
English
ISSN
1415-4757
Abstract
Coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus type 2 (SARS-CoV-2), is the largest pandemic in modern history with very high infection rates and considerable mortality. The disease, which emerged in China’s Wuhan province, had its first reported case on December 29, 2019, and spread rapidly worldwide. On March 11, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a pandemic and global health emergency. Since the outbreak, efforts to develop COVID-19 vaccines, engineer new drugs, and evaluate existing ones for drug repurposing have been intensively undertaken to find ways to control this pandemic. COVID-19 therapeutic strategies aim to impair molecular pathways involved in the virus entrance and replication or interfere in the patients’ overreaction and immunopathology. Moreover, nanotechnology could be an approach to boost the activity of new drugs. Several COVID-19 vaccine candidates have received emergency-use or full authorization in one or more countries, and others are being developed and tested. This review assesses the different strategies currently proposed to control COVID-19 and the issues or limitations imposed on some approaches by the human and viral genetic variability.